What's new in general thoracic surgery

Journal of the American College of Surgeons

Volumn 195, Issue 1, 2002, Pages 55-71

  Miller Jr , Joseph L ^a,b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Carlyle Fraser Heart Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; CARBOPLATIN; CISPLATIN; ETOPOSIDE; FLUORODEOXYGLUCOSE F 18; MITOMYCIN; PACLITAXEL; SILICONE; VINBLASTINE;

ACCREDITATION; ADOLESCENT; ADULT; CANCER SURGERY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; EMPHYSEMA; ESOPHAGUS ACHALASIA; ESOPHAGUS CANCER; ESOPHAGUS DISEASE; FEMALE; GASTROESOPHAGEAL REFLUX; HIATUS HERNIA; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; INFECTIOUS ARTHRITIS; LUNG CANCER; LUNG FUNCTION; LUNG NON SMALL CELL CANCER; LUNG RESECTION; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MEDIASTINUM TUMOR; MESOTHELIOMA; MYASTHENIA GRAVIS; PHASE 2 CLINICAL TRIAL; POSITRON EMISSION TOMOGRAPHY; POSTGRADUATE EDUCATION; PRIORITY JOURNAL; REFLUX ESOPHAGITIS; REVIEW; STERNOCLAVICULAR JOINT; SURGEON; SURGICAL TECHNIQUE; SURGICAL TRAINING; THORAX SURGERY; THYMOMA;

EID: 0036300658     PISSN: 10727515     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1072-7515(02)01240-1     Document Type: Article

References (55)

1. Changes in the wind
2. The influence of hospital volume on survival after resection for lung cancer
3. Impact of comorbidity on survival after surgical resection in patients with stage I non-small cell lung cancer
4. The significance of intraoperative pleural effusion during surgery for bronchogenic carcinoma
5. Malignant minor pleural effusion detected on thoracotomy for patients with non-small cell lung cancer: Is tumor resection beneficial for prognosis?
6. Natural history of pure ground-glass opacity after long term follow-up of more than 2 years
7. Bronchioalveolar carcinoma of the lung: Recurrences and survival in patients with stage I disease
8. Preoperative chemotherapy for lung cancer does not increase surgical morbidity
9. Induction chemoradiation and surgical resection for non-small cell lung carcinomas of the superior sulcus: Initial results of Southwest Oncology Group Trial 9416
10. Can FDG-PET reduce the need for mediastinoscopy in potentially resectable non-small cell lung cancer
11. Endoscopic ultrasound-guided fine needle aspiration for staging patients with carcinoma of the lung
12. Molecular assessment of lymph nodes in patients with resected stage I non-small cell lung cancer: Preliminary results of a prospective study
13. Predicting the sites of metastasis from lung cancer using molecular biologic markers
14. Pneumonectomy for malignant disease: Factors affecting early morbidity and mortality
15. Morbidity and mortality after neoadjuvant therapy for lung cancer: The risk of right pneumonectomy
16. Frequency and mortality of acute lung injury and acute respirating distress syndrome after pulmonary resection for bronchogenic carcinoma
17. Prediction of early bronchopleural fistula after pneumonectomy: A multivariate analysis
18. Resection of bronchogenic carcinoma involving the carina: Long term results and effect of nodal status on outcome
19. Resection of adrenal metastasis from non-small cell lung cancer: A multicenter study
20. Hospital readmission after pulmonary resection: Prevalence, patterns, and predisposing characteristics
21. Empyema and bronchopleural fistula after pneumonectomy: Factors affecting incidence
22. Current strategy for surgical management of bronchiectasis
23. Trial of a novel sealant in preventing air leaks after lung resection
24. A comparative study of buttressed versus nonbuttressed staple line in pulmonary resections
25. Lobar torsion after pulmonary resection: Presentation and outcome
26. Endotracheal balloon dilatation and stent implantation in benign stenosis
27. Management of congenital tracheal slide tracheoplasty or resection and reconstruction with long term follow-up of growth after slide tracheoplasty
28. Impact of hospital volume on clinical and economic outcomes for esophagectomy
29. The pattern of metastatic lymph node dissemination from adenocarcinoma of the esophagogastric junction
30. Transthoracic esophagectomy with radical mediastinal and abdominal lymph node dissection and cervical esophagogastrectomy for esophageal carcinoma
31. Neoadjuvant therapy of esophageal squamous cell carcinoma: Response evaluation by position emission tomography
32. Should en bloc esophagectomy be the standard of care for esophageal carcinoma
33. Curative resection for esophageal adenocarcinoma: Analysis of 100 en bloc esophagectomies
34. Salvage esophagectomy for recurrent tumors after definitive chemotherapy and radiotherapy
35. Superficial adenocarcinoma of the esophagus
36. Long term nonsurgical management of Barrett's esophagus with high-grade dysplasia
37. Critical appraisal of the significance of intrathoracic anastomotic leakage after esophagectomy for cancer
38. Long term outcome of medical and surgical therapies for gastroesophageal reflux disease: Follow-up of a randomized controlled trial
39. Results of Collis gastroplasty and selective fundoplasty using a left thoracoabdominal approach for failed antireflux surgery
40. Outcomes after minimally invasive esophagomyotomy
41. Laparoscopic repair of large paraesophageal hiatal hernia
42. Esophagectomy for achalasia: Patient selection and clinical experience
43. Descending necrotizing mediastinitis: Surgical management
44. Neuroendocrine tumors of the thymus: A clinicopathological and prognostic study
45. Predictors of outcome in thymectomy for myasthenia gravis
46. Early complications of thoracic endoscopic sympathectomy: A prospective study of 940 procedures
47. A phase II trial of surgical resection and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma
48. Current presentation and optimal surgical management of sternoclavicular infections
49. Lung function 5 years after lung volume reduction surgery for emphysema
50. Long-term results of lung volume reduction surgery
51. Improved long-term survival seen after lung volume reduction surgery compared to continual medical therapy for emphysema
52. The National Emphysema Treatment Trial: A paradigm for future surgical trials
53. Paying the piper: The NETT strikes a sour note
54. Bilateral versus single lung transplant for chronic obstructive pulmonary disease: Intermediate-term results
55. Lung transplantation for pulmonary vascular disease